ANI PHARMACEUTICALS I

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET

18 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension

09 4 2024 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis

04 4 2024 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium

03 4 2024 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP

27 3 2024 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance

29 2 2024 06:50:01 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference

20 2 2024 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ET

07 2 2024 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference

29 1 2024 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP

23 1 2024 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP

16 1 2024 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

22 11 2023 09:26:49 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

08 11 2023 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

30 10 2023 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET

25 10 2023 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares

02 10 2023 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

18 9 2023 16:05:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP

12 9 2023 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%

28 8 2023 06:50:00 提供 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

24 8 2023 06:50:00 提供 Nasdaq GlobeNewswire